ArticleAnaesthesia2026
Organisational practices in postoperative opioid prescribing at discharge in UK NHS day surgery units: the OPIOID-discharge survey.
Article in Anaesthesia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionIn March 2025, the Medicines and Healthcare products Regulatory Agency published a drug safety update removing the indication of postoperative pain from the licence of prolonged-release opioids and mandated discussing risks with patients. Our study assessed compliance with these recommendations 6 months post-publication.
methodsA cross-sectional survey on organisational discharge opioid prescribing practices was distributed via the National Confidential Enquiry into Patient Outcome and Death Local Reporter pathway to acute hospitals in England, Wales and Northern Ireland. Surveys targeted Day Surgery Unit managers and Drugs and Therapeutics Committee secretaries.
resultsWe received responses from 83 Day Surgery Units and 70 Drug and Therapeutics Committees (approximately 68% response rate). Before March 2025, 51/70 (73%) Trusts routinely used modified-release opioids. Following the drug safety update, 59/70 (84%) committees shared the guidance and, consequently, 38/51 (75%) organisations that previously used modified-release opioids no longer do so. However, 10/70 (14%) units still dispensed modified-release opioids. Among day surgery units dispensing opioids, only 19/60 (32%) provided discharge letters that advised general practitioners against repeat prescriptions and 17/60 (28%) units provided patient information on opioid risks. Formal training on acute postoperative pain management was confirmed for only 22/83 (27%) responding units. DISCUSSION: Six months after the drug safety update, there is evidence of significant impact, with most Trusts sharing the alert and moving away from modified-release opioids. However, substantial work is still required. Key gaps include continued dispensing of modified-release and combination opioids, and poor communication with patients and general practitioners regarding opioid risks and safe disposal.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.